Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer.

Erdoğar N., Esendağlı G., Nielsen T., Esendağlı-Yılmaz G., Yöyen-Ermiş D., Erdoğdu B., ...More

Journal of drug targeting, vol.26, pp.66-74, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26
  • Publication Date: 2018
  • Doi Number: 10.1080/1061186x.2017.1339194
  • Journal Name: Journal of drug targeting
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.66-74
  • Keywords: Paclitaxel, nanoparticle, folate, amphiphilic cyclodextrin, breast cancer, IN-VIVO EVALUATION, DRUG-DELIVERY, CARBON NANOTUBES, TAXOL, FORMULATION, CELLS, VITRO, RELEASE, CAMPTOTHECIN, CHEMOTHERAPY
  • Bursa Uludag University Affiliated: No


Purpose: The aim of this study is to test folate-conjugated cyclodextrin nanoparticles (FCD-1 and FCD-2) as a vehicle for reducing toxicity and increasing the antitumor efficacy of paclitaxel especially for metastatic breast cancer.